Addressing Obesity and Atrial Fibrillation: A Comprehensive Overview

This chapter discusses the impact of glucagon-like peptide-1 receptor agonists on obesity management and the critical need for inclusive healthcare solutions. It further examines atrial fibrillation as a chronic condition and provides guidance on engaging adolescents in sexual and reproductive health discussions.